Global Peptide Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 239 pages | ID: G0AB396F3549EN
Bosson Research

Abstracts

Report Overview

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.

This report provides a deep insight into the global Peptide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Vaccine market in any manner.

Global Peptide Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Anergis

Antigen Express

Apitope Technology

Artificial Cell Technologies

Benovus Bio

Celgene Corporation

Immatics biotechnologies

Merck

ImmunoCellular Therapeutics

ISA Pharmaceuticals

Lytix Biopharma

Spotlight Innovation

OncoTherapy Science

Peptech

Pharmasyntez

Sumitomo Dainippon Pharma

TapImmune

Targovax

Market Segmentation (by Type)

Solution Phase Synthesis (SPS)

Solid Phase Peptide Synthesis (SPPS)

Market Segmentation (by Application)

Prostate Cancer

Breast Cancer

Gastric Cancer

Lung Cancer

Pancreatic Cancer

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Peptide Vaccine Market
• Overview of the regional outlook of the Peptide Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Peptide Vaccine
1.2 Key Market Segments
  1.2.1 Peptide Vaccine Segment by Type
  1.2.2 Peptide Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL PEPTIDE VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Peptide Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Peptide Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL PEPTIDE VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Peptide Vaccine Product Life Cycle
3.3 Global Peptide Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Peptide Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peptide Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Peptide Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Peptide Vaccine Market Competitive Situation and Trends
  3.8.1 Peptide Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Peptide Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PEPTIDE VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Peptide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Peptide Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Peptide Vaccine Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL PEPTIDE VACCINE MARKET BY REGION

6.1 Global Peptide Vaccine Market Size by Region
  6.1.1 Global Peptide Vaccine Market Size by Region
  6.1.2 Global Peptide Vaccine Market Size Market Share by Region
6.2 Global Peptide Vaccine Sales by Region
  6.2.1 Global Peptide Vaccine Sales by Region
  6.2.2 Global Peptide Vaccine Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Peptide Vaccine Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Peptide Vaccine Market Size by Type
7.3 North America Peptide Vaccine Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Peptide Vaccine Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Peptide Vaccine Market Size by Type
8.3 Europe Peptide Vaccine Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Peptide Vaccine Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Peptide Vaccine Market Size by Type
9.3 Asia-Pacific Peptide Vaccine Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Peptide Vaccine Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Peptide Vaccine Market Size by Type
10.3 South America Peptide Vaccine Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Peptide Vaccine Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Peptide Vaccine Market Size by Type
11.3 Middle East and Africa Peptide Vaccine Market Size by Application

12 PEPTIDE VACCINE MARKET PRODUCTION BY REGION

12.1 Global Production of Peptide Vaccine by Region(2020-2025)
12.2 Global Peptide Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Peptide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Peptide Vaccine Production
  12.4.1 North America Peptide Vaccine Production Growth Rate (2020-2025)
  12.4.2 North America Peptide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Peptide Vaccine Production
  12.5.1 Europe Peptide Vaccine Production Growth Rate (2020-2025)
  12.5.2 Europe Peptide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Peptide Vaccine Production (2020-2025)
  12.6.1 Japan Peptide Vaccine Production Growth Rate (2020-2025)
  12.6.2 Japan Peptide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Peptide Vaccine Production (2020-2025)
  12.7.1 China Peptide Vaccine Production Growth Rate (2020-2025)
  12.7.2 China Peptide Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

13 PEPTIDE VACCINE MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Peptide Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Peptide Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Peptide Vaccine Price by Type (2020-2033)

14 PEPTIDE VACCINE MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Peptide Vaccine Market Sales by Application (2020-2033)
14.3 Global Peptide Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Peptide Vaccine Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Anergis
  15.1.1 Anergis Basic Information
  15.1.2 Anergis Peptide Vaccine Product Overview
  15.1.3 Anergis Peptide Vaccine Product Market Performance
  15.1.4 Anergis Business Overview
  15.1.5 Anergis SWOT Analysis
  15.1.6 Anergis Recent Developments
15.2 Antigen Express
  15.2.1 Antigen Express Basic Information
  15.2.2 Antigen Express Peptide Vaccine Product Overview
  15.2.3 Antigen Express Peptide Vaccine Product Market Performance
  15.2.4 Antigen Express Business Overview
  15.2.5 Antigen Express SWOT Analysis
  15.2.6 Antigen Express Recent Developments
15.3 Apitope Technology
  15.3.1 Apitope Technology Basic Information
  15.3.2 Apitope Technology Peptide Vaccine Product Overview
  15.3.3 Apitope Technology Peptide Vaccine Product Market Performance
  15.3.4 Apitope Technology Business Overview
  15.3.5 Apitope Technology SWOT Analysis
  15.3.6 Apitope Technology Recent Developments
15.4 Artificial Cell Technologies
  15.4.1 Artificial Cell Technologies Basic Information
  15.4.2 Artificial Cell Technologies Peptide Vaccine Product Overview
  15.4.3 Artificial Cell Technologies Peptide Vaccine Product Market Performance
  15.4.4 Artificial Cell Technologies Business Overview
  15.4.5 Artificial Cell Technologies Recent Developments
15.5 Benovus Bio
  15.5.1 Benovus Bio Basic Information
  15.5.2 Benovus Bio Peptide Vaccine Product Overview
  15.5.3 Benovus Bio Peptide Vaccine Product Market Performance
  15.5.4 Benovus Bio Business Overview
  15.5.5 Benovus Bio Recent Developments
15.6 Celgene Corporation
  15.6.1 Celgene Corporation Basic Information
  15.6.2 Celgene Corporation Peptide Vaccine Product Overview
  15.6.3 Celgene Corporation Peptide Vaccine Product Market Performance
  15.6.4 Celgene Corporation Business Overview
  15.6.5 Celgene Corporation Recent Developments
15.7 Immatics biotechnologies
  15.7.1 Immatics biotechnologies Basic Information
  15.7.2 Immatics biotechnologies Peptide Vaccine Product Overview
  15.7.3 Immatics biotechnologies Peptide Vaccine Product Market Performance
  15.7.4 Immatics biotechnologies Business Overview
  15.7.5 Immatics biotechnologies Recent Developments
15.8 Merck
  15.8.1 Merck Basic Information
  15.8.2 Merck Peptide Vaccine Product Overview
  15.8.3 Merck Peptide Vaccine Product Market Performance
  15.8.4 Merck Business Overview
  15.8.5 Merck Recent Developments
15.9 ImmunoCellular Therapeutics
  15.9.1 ImmunoCellular Therapeutics Basic Information
  15.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Overview
  15.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product Market Performance
  15.9.4 ImmunoCellular Therapeutics Business Overview
  15.9.5 ImmunoCellular Therapeutics Recent Developments
15.10 ISA Pharmaceuticals
  15.10.1 ISA Pharmaceuticals Basic Information
  15.10.2 ISA Pharmaceuticals Peptide Vaccine Product Overview
  15.10.3 ISA Pharmaceuticals Peptide Vaccine Product Market Performance
  15.10.4 ISA Pharmaceuticals Business Overview
  15.10.5 ISA Pharmaceuticals Recent Developments
15.11 Lytix Biopharma
  15.11.1 Lytix Biopharma Basic Information
  15.11.2 Lytix Biopharma Peptide Vaccine Product Overview
  15.11.3 Lytix Biopharma Peptide Vaccine Product Market Performance
  15.11.4 Lytix Biopharma Business Overview
  15.11.5 Lytix Biopharma Recent Developments
15.12 Spotlight Innovation
  15.12.1 Spotlight Innovation Basic Information
  15.12.2 Spotlight Innovation Peptide Vaccine Product Overview
  15.12.3 Spotlight Innovation Peptide Vaccine Product Market Performance
  15.12.4 Spotlight Innovation Business Overview
  15.12.5 Spotlight Innovation Recent Developments
15.13 OncoTherapy Science
  15.13.1 OncoTherapy Science Basic Information
  15.13.2 OncoTherapy Science Peptide Vaccine Product Overview
  15.13.3 OncoTherapy Science Peptide Vaccine Product Market Performance
  15.13.4 OncoTherapy Science Business Overview
  15.13.5 OncoTherapy Science Recent Developments
15.14 Peptech
  15.14.1 Peptech Basic Information
  15.14.2 Peptech Peptide Vaccine Product Overview
  15.14.3 Peptech Peptide Vaccine Product Market Performance
  15.14.4 Peptech Business Overview
  15.14.5 Peptech Recent Developments
15.15 Pharmasyntez
  15.15.1 Pharmasyntez Basic Information
  15.15.2 Pharmasyntez Peptide Vaccine Product Overview
  15.15.3 Pharmasyntez Peptide Vaccine Product Market Performance
  15.15.4 Pharmasyntez Business Overview
  15.15.5 Pharmasyntez Recent Developments
15.16 Sumitomo Dainippon Pharma
  15.16.1 Sumitomo Dainippon Pharma Basic Information
  15.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
  15.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product Market Performance
  15.16.4 Sumitomo Dainippon Pharma Business Overview
  15.16.5 Sumitomo Dainippon Pharma Recent Developments
15.17 TapImmune
  15.17.1 TapImmune Basic Information
  15.17.2 TapImmune Peptide Vaccine Product Overview
  15.17.3 TapImmune Peptide Vaccine Product Market Performance
  15.17.4 TapImmune Business Overview
  15.17.5 TapImmune Recent Developments
15.18 Targovax
  15.18.1 Targovax Basic Information
  15.18.2 Targovax Peptide Vaccine Product Overview
  15.18.3 Targovax Peptide Vaccine Product Market Performance
  15.18.4 Targovax Business Overview
  15.18.5 Targovax Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peptide Vaccine Market Size by Type (M USD)
Table 4. Global Peptide Vaccine Market Size by Application (M USD)
Table 5. Peptide Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Peptide Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Peptide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peptide Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peptide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2024)
Table 11. Global Market Peptide Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Peptide Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Peptide Vaccine Product Type
Table 14. Global Peptide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Peptide Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Peptide Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Peptide Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Peptide Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Peptide Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Peptide Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Peptide Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Peptide Vaccine Sales by Type (K MT)
Table 33. North America Peptide Vaccine Market Size by Type (M USD)
Table 34. North America Peptide Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Peptide Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Peptide Vaccine Sales by Application (K MT)
Table 37. North America Peptide Vaccine Market Size by Application (M USD)
Table 38. North America Peptide Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Peptide Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Peptide Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Peptide Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Peptide Vaccine Sales by Type (K MT)
Table 43. Europe Peptide Vaccine Market Size by Type (M USD)
Table 44. Europe Peptide Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Peptide Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Peptide Vaccine Sales by Application (K MT)
Table 47. Europe Peptide Vaccine Market Size by Application (M USD)
Table 48. Europe Peptide Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Peptide Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Peptide Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Peptide Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Peptide Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Peptide Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Peptide Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Peptide Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Peptide Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Peptide Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Peptide Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Peptide Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Peptide Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Peptide Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Peptide Vaccine Sales by Type (K MT)
Table 63. South America Peptide Vaccine Market Size by Type (M USD)
Table 64. South America Peptide Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Peptide Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Peptide Vaccine Sales by Application (K MT)
Table 67. South America Peptide Vaccine Market Size by Application (M USD)
Table 68. South America Peptide Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Peptide Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Peptide Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Peptide Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Peptide Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Peptide Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Peptide Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Peptide Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Peptide Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Peptide Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Peptide Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Peptide Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Peptide Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Peptide Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Peptide Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Peptide Vaccine Sales by Type (K MT)
Table 89. Global Peptide Vaccine Market Size by Type (M USD)
Table 90. Global Peptide Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Peptide Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Peptide Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Peptide Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Peptide Vaccine Sales (K MT) by Application
Table 95. Global Peptide Vaccine Market Size by Application(M USD)
Table 96. Global Peptide Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Peptide Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Peptide Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Peptide Vaccine Market Share by Application (2020-2033)
Table 100. Global Peptide Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Anergis Basic Information
Table 102. Anergis Peptide Vaccine Product Overview
Table 103. Anergis Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Anergis Business Overview
Table 105. Anergis SWOT Analysis
Table 106. Anergis Recent Developments
Table 107. Antigen Express Basic Information
Table 108. Antigen Express Peptide Vaccine Product Overview
Table 109. Antigen Express Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Antigen Express Business Overview
Table 111. Antigen Express SWOT Analysis
Table 112. Antigen Express Recent Developments
Table 113. Apitope Technology Basic Information
Table 114. Apitope Technology Peptide Vaccine Product Overview
Table 115. Apitope Technology Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Apitope Technology Business Overview
Table 117. Apitope Technology SWOT Analysis
Table 118. Apitope Technology Recent Developments
Table 119. Artificial Cell Technologies Basic Information
Table 120. Artificial Cell Technologies Peptide Vaccine Product Overview
Table 121. Artificial Cell Technologies Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Artificial Cell Technologies Business Overview
Table 123. Artificial Cell Technologies Recent Developments
Table 124. Benovus Bio Basic Information
Table 125. Benovus Bio Peptide Vaccine Product Overview
Table 126. Benovus Bio Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Benovus Bio Business Overview
Table 128. Benovus Bio Recent Developments
Table 129. Celgene Corporation Basic Information
Table 130. Celgene Corporation Peptide Vaccine Product Overview
Table 131. Celgene Corporation Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Celgene Corporation Business Overview
Table 133. Celgene Corporation Recent Developments
Table 134. Immatics biotechnologies Basic Information
Table 135. Immatics biotechnologies Peptide Vaccine Product Overview
Table 136. Immatics biotechnologies Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Immatics biotechnologies Business Overview
Table 138. Immatics biotechnologies Recent Developments
Table 139. Merck Basic Information
Table 140. Merck Peptide Vaccine Product Overview
Table 141. Merck Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Merck Business Overview
Table 143. Merck Recent Developments
Table 144. ImmunoCellular Therapeutics Basic Information
Table 145. ImmunoCellular Therapeutics Peptide Vaccine Product Overview
Table 146. ImmunoCellular Therapeutics Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. ImmunoCellular Therapeutics Business Overview
Table 148. ImmunoCellular Therapeutics Recent Developments
Table 149. ISA Pharmaceuticals Basic Information
Table 150. ISA Pharmaceuticals Peptide Vaccine Product Overview
Table 151. ISA Pharmaceuticals Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. ISA Pharmaceuticals Business Overview
Table 153. ISA Pharmaceuticals Recent Developments
Table 154. Lytix Biopharma Basic Information
Table 155. Lytix Biopharma Peptide Vaccine Product Overview
Table 156. Lytix Biopharma Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Lytix Biopharma Business Overview
Table 158. Lytix Biopharma Recent Developments
Table 159. Spotlight Innovation Basic Information
Table 160. Spotlight Innovation Peptide Vaccine Product Overview
Table 161. Spotlight Innovation Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Spotlight Innovation Business Overview
Table 163. Spotlight Innovation Recent Developments
Table 164. OncoTherapy Science Basic Information
Table 165. OncoTherapy Science Peptide Vaccine Product Overview
Table 166. OncoTherapy Science Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. OncoTherapy Science Business Overview
Table 168. OncoTherapy Science Recent Developments
Table 169. Peptech Basic Information
Table 170. Peptech Peptide Vaccine Product Overview
Table 171. Peptech Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Peptech Business Overview
Table 173. Peptech Recent Developments
Table 174. Pharmasyntez Basic Information
Table 175. Pharmasyntez Peptide Vaccine Product Overview
Table 176. Pharmasyntez Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Pharmasyntez Business Overview
Table 178. Pharmasyntez Recent Developments
Table 179. Sumitomo Dainippon Pharma Basic Information
Table 180. Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
Table 181. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Sumitomo Dainippon Pharma Business Overview
Table 183. Sumitomo Dainippon Pharma Recent Developments
Table 184. TapImmune Basic Information
Table 185. TapImmune Peptide Vaccine Product Overview
Table 186. TapImmune Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. TapImmune Business Overview
Table 188. TapImmune Recent Developments
Table 189. Targovax Basic Information
Table 190. Targovax Peptide Vaccine Product Overview
Table 191. Targovax Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Targovax Business Overview
Table 193. Targovax Recent Developments
List of Figures
Figure 1. Product Picture of Peptide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Peptide Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Peptide Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peptide Vaccine Product Life Cycle
Figure 13. Peptide Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Peptide Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Peptide Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peptide Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Peptide Vaccine
Figure 19. Global Peptide Vaccine Market PEST Analysis
Figure 20. Global Peptide Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Peptide Vaccine Market Size by Region
Figure 27. Global Peptide Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Peptide Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Peptide Vaccine Market Size (M USD) by Country
Figure 33. USA Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Peptide Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Peptide Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Peptide Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Peptide Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Peptide Vaccine Market Size (M USD)by Type
Figure 40. North America Peptide Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Peptide Vaccine Market Size (M USD) by Country
Figure 45. Germany Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Peptide Vaccine Market Size (M USD) by Type
Figure 56. Europe Peptide Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Peptide Vaccine Market Size (M USD) by Country
Figure 61. China Peptide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Peptide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Peptide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Peptide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Peptide Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Peptide Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Peptide Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Peptide Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Peptide Vaccine Market Size (M USD) by Country
Figure 77. Brazil Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Peptide Vaccine Market Size (M USD) by Type
Figure 84. South America Peptide Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Peptide Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Peptide Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Peptide Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Peptide Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Peptide Vaccine Market Size (M USD) by Application
Figure 101. Global Peptide Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Peptide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Peptide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Peptide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Peptide Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Peptide Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Peptide Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Peptide Vaccine by Type in 2024
Figure 110. Market Size Share of Peptide Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Peptide Vaccine by Type in 2024
Figure 112. Global Peptide Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Peptide Vaccine Market Size by Application(M USD)
Figure 115. Global Peptide Vaccine Market Share by Application
Figure 116. Global Peptide Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Peptide Vaccine Sales Market Share by Application in 2024
Figure 118. Global Peptide Vaccine Market Share by Application (2020-2033)
Figure 119. Global Peptide Vaccine Market Share by Application in 2024
Figure 120. Global Peptide Vaccine Sales Growth Rate by Application (2020-2033)